The Intestinal Microbiome and Estrogen Receptor–Positive Female Breast Cancer
Maryann Kwa(NYU Langone Health), Sylvia Adams(NYU Langone Health)
Cited by 521
Related Papers
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
|Journal of Clinical Oncology|2014|1.3k
Current Landscape of Immunotherapy in Breast Cancer
|JAMA Oncology|2019|409
Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
|Clinical Cancer Research|2012|225
Performance of PD-L1 immunohistochemistry (IHC) assays in unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC): Post-hoc analysis of IMpassion130
|Annals of Oncology|2019|115
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer
|npj Breast Cancer|2019|86